This study provides novel insights into the pathogenesis of RP-ILD development in MDA5+ DM and suggests the plasma protein SPP1 could serve as a potential blood biomarker for RP-ILD early warning. The gene discussed is SPP1; the disease is retinitis pigmentosa 1.